go-v.orgdoi

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

Soufiane Ghannam, Carine Bouffi, Farida Djouad, Christian Jørgensen, Danièle Noël · Stem Cell Research & Therapy · 2010

  • DOI 10.1186/scrt2
  • Publisher BioMed Central
  • Type article
  • Issued 2010

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Stem Cell Research & Therapy · BioMed Central · article · 2010

Abstract

Mesenchymal stem cells (MSCs) are multipotential nonhematopoietic progenitor cells that are isolated from many adult tissues, in particular from the bone marrow and adipose tissue. Along with their capacity for differentiating into cells of mesodermal lineage, such as adipocytes, osteoblasts and chondrocytes, these cells have also generated great interest for their ability to display immunomodulatory capacities. Indeed, a major breakthrough came with the finding that they are able to induce peripheral tolerance, suggesting they may be used as therapeutic tools in immune-mediated disorders.

The present review aims at discussing the current knowledge on the targets and mechanisms of MSC-mediated immunosuppression as well as the potential use of MSCs as modulators of immune responses in a variety of diseases related to alloreactive immunity or autoimmunity.

Open the resolved locator · 10.1186/scrt2

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 02:18 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://link.springer.com/article/10.1186/scrt2
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.